This study aims to understand seizure control outcomes and the risk of developing new wake seizures (WS) related to the different types of pure sleep epilepsies (SE), which is important in making rational management plans. A retrospective review of the Yonsei Epilepsy Clinic Registry identified 63 patients with pure SE not belonging to any specific epileptic syndromes. They were divided into the group of generalized tonic-clonic seizures during sleep (S-GTCS : n = 21) and the group of partial epilepsies during sleep (S-PE : n = 42) on the basis of seizure phenomenology, EEG. and neuroimaging data. These patients were followed for 2 years and their clinical variables were analysed for seizure control outcomes and development of new WS. Of 21 patients with S-GTCS, I7 achieved a seizure-free outcome and only one patient developed a new WS, which was consistent with a partial-onset secondary GTCS in phenomenology. Of 42 patients with S-PE only I5 patients achieved a seizure-free outcome and I I patients developed WS during the 2-year follow-up period. Higher baseline seizure frequency and longer duration of epilepsy were associated with a higher incidence of new WS. The results suggest that the patients with S-GTCS carry a favorable clinical course, thus driving privileges or freedom of daily activities can be conferred without delay once their seizures are well controlled. However, the seizure control outcome was poor and the development of WS was frequent in patients with recurrent S-PE.
INTRODUCTION
Sleep epilepsy (SE), i.e. recurrent seizures during sleep, implies important medico-legal or social significance to the patient's daily life. Investigations into the clinical course of SE are mandatory for their proper management.
Previously, SE has been divided into the pure SE (seizure recurrences exclusively during sleep) and the predominant SE. Young et al' disclosed different clinical characteristics in the two groups of SE. Pure SE was associated with a higher proportion of GTCS, lower frequency of seizure recurrences, lower incidence of identifiable etiologies of seizure, and less abnormal neurological examinations compared with predominant SE. Previous studies2v3 often included both types of SE and reported a relatively high incidence of SE (30% to 45%), while the incidence of pure SE reported in more recent studies'q4q5 were around 5% to 7.5%. These suggest that pure SE is a different clinical group from predominant SE.
Previous efforts to identify the SE as a distinct clinical entity6*7 have been hampered by the many differ-1059-l 311/98/050369 + 09 $12.00/O ent clinical features found in this group of patients. The seizure types seen in these patients were usually either generalized tonic-clonic seizures (GTCS) or complex partial seizures (CPS) but simple partial seizures were also described'*4.7. In addition, SE can be found in patients with many different epileptic syndromes, i.e. benign rolandic epilepsy5, temporal lobe epilepsys, frontal lobe epilepsy', or idiopathic generalized epilepsies 5* lo. Insufficient description of epileptic attacks is also a problem with SE. Because of its occurrence during sleep the patient is not aware of the occurrence of auras or the attacks, and may wake up in the morning with a bitten tongue, evidence of enuresis, headache, or even without any specific complaints. Observers are often absent or they frequently fail to observe the initial part of epileptic attacks which is essential for correct diagnosis of seizure type. These factors often make the correct diagnosis of seizure type difficult and the international classification of epilepsies and epileptic syndromes " has included the nocturnal grand mals in the category 3.2, 'epilepsies and syndromes undetermined whether focal or generalized'.
Another problem with SE is the occasional occur-rence of wake seizures (WS) in patients who initially presented with pure SE. Janz2 reported that 20% of nocturnal grand ma1 epilepsies become diffuse in circadian rhythms on prolonged follow-up. Gibberd and Bateson found that 35 of 64 patients with SE had continuing sleep attacks, 15 stopped having attacks, and 16 started WS at the end of 3 years of follow-up. After 3 years the incidence of WS decreased significantly but some patients still developed WS after many years of pure SE. On the other hand, D'Allesandro et al5 reported that only four of 34 patients with sleep GTCS developed WS during 2 years of follow-up and all four patients had their seizure onset less than 2 years before their initial visit. These results suggest that SE includes many heterogeneous epileptic syndromes with variable degrees of interaction with the sleep-wake cycle. This study was conducted to discover the clinical course of pure SE in relation to seizure type.
PATIENTS AND METHODS

Patients
We retrospectively reviewed the epilepsy clinic registry and the medical records of the patients newly attending the Yonsei Epilepsy Clinic (YEC) during the period from 1 January 1990 to 3 1 August 1994. The YEC registry included a thorough history of past illnesses, family history of epilepsies, description of seizure phenomenology, timing of seizure attacks, seizure frequencies and previous history of antiepileptic drugs (AEDs) therapy. All patients underwent a 60minute recording of a 21-channel scalp EEG after overnight sleep deprivation with routinely employed 7'1, T2 and nasopharyngeal electrodes. At least one neuroimaging study, either CT scan or MRJ, was recommended to all patients. The timing of recurrent seizures related to the sleep-wake cycle was specified either on the seizure diary or medical charts on their regular visits, which was confirmed further, if necessary, by telephone conversations. The patient inclusion criteria were (i) exclusive occurrence of epileptic attacks during sleep before their initial evaluation, (ii) at least two or more unprovoked seizures, (iii) longer than 2 years of follow-up. We excluded the patients if their seizures occurred at awakening or if they belonged to well-defined epileptic syndromes, i.e. benign rolandic epilepsy, juvenile myoclonic epilepsy, juvenile absence epilepsy, etc.
Classification of sleep epilepsies
According to the guidelines of international classification of epileptic seizures t* , the descriptions of epileptic attacks are divided into grand ma1 seizures (GMS) and partial seizures with or without secondary generalized tonic-clonic seizures (PS). GMS included generalized convulsive seizures without any documented focal features (the descriptions were either complete or incomplete) and PS included non-convulsive seizures, unilateral or asymmetric convulsive seizures, or GMS preceded by either non-convulsive behavioral changes or the presence of auras. The phenomenological classification of epileptic attacks was further supplemented by the data from EEG and neuroimaging studies. The EEG features were divided into (i) non-localizing, when the EEG was either normal or showed diffuse background abnormalities or generalized spike and wave complexes (SWC) and (ii) focal, when the EEG showed focal interictal epileptiform discharges (IBDs). The presence of focal lesions in neuroimaging studies was considered as evidence of PS. However, the lesions of questionable clinical significance, i.e. arachnoid cyst, venous angioma, and increased Tz-signal intensities in the white matter, etc., were not considered as evidence of PS.
Although a history of remote CNS insults might suggest the presence of focal pathologies, its relationship with the seizure type or epileptic syndrome has not yet been clearly established, therefore it was not considered for the classification of seizure types in this study.
Clinical courses
All patients kept seizure diaries during their clinic visits every 4 to 8 weeks. Their seizure recurrence and the timing of seizure occurrence in relation to sleep was recorded on the chart.
The principles of AEDs treatment were initial maximally tolerable monotherapy followed by either alternative monotherapy or polytherapy. The choice of initial AEDs was dependent upon the AEDs taken previously as well as the type of seizures. Of 41 patients under AEDs therapy at their initial evaluation, 24 patients were taking single AED therapy: phenytoin (PHT) in 10 patients, carbamazepine (CBZ) in six patients, phenobarbital (PB) in four patients, sodium valproate (VPA) in four patients, and 17 patients were under polytherapy. At the end of the 2-year follow-up, 33 patients were taking single AED treatment (CBZ, 18 patients; VPA, nine patients; PHT, five patients; PB, one patient) and eight patients were taking polytherapy. Of 22 patients new to AEDs, only one patient was taking two AEDs by the end of the 2-year follow-up. Eleven patients were under CBZ monotherapy, eight patients were taking VPA, and one patient was taking PHT. VPA monotherapy was the most common drug therapy in the group of S-GTCS (n = 12) as was CBZ monotherapy in the group of S-PE (n = 24). Blood levels of AEDs were measured selectively on the basis of clinical judgments.
The responses to the AEDs therapy were divided into three groups: (i) seizure-free, if the patients did not have any seizures for the second year of follow-up; (ii) improved, if the number of recurrent seizures during the second year of follow-up was reduced by 50% or more from the baseline frequency of seizures at their initial evaluation; (iii) not improved, if the number of seizures during the second year of follow-up was greater than 50% of the baseline seizure frequencies.
Statistics
Statistical analyses were performed with the SAS program. Firstly, f-tests or chi-squared tests were used to compare the clinical characteristics of the S-PE and S-GTCS groups, the seizure-free and recurrent seizure groups, and the groups with sleep seizures alone and with WS. Secondly, the stepwise multiple logistic regression test was used to confirm the risk factors and to calculate the odd ratios with 95% confidence intervals of the selected variables.
RESULTS
Initially, ninety-five patients were found to have pure SE among 2000 patients who were newly registered to the YEC during the study period. Of those, 63 patients satisfied the inclusion criteria and were analysed. Twelve patients were identified as having benign rolandic epilepsy, one patient had juvenile myoclonic epilepsy, 10 patients were lost before the 2 years of follow-up, three patients were treated for a single episode of nocturnal seizure, and the timing of subsequent seizure recurrences in relation with the sleep-wake cycle could not be clearly identified in six patients.
Classification of seizure types
The details of seizure phenomenology clearly suggested PS in 26 patients and GMS without clear focal features in the remaining 37 patients. EEGs disclosed focal IEDs in 23 patients and generalized SWC in four patients. Neuroimaging studies were conducted in 61 of 63 patients, with CT scans in 22 patients and MRl in 39 patients. Focal lesions were found in 11 patients (CT scan, three patients; MRI, eight patients). On the basis of combined seizure phenomenology, EEG and neuroimaging data, 21 of 37 patients with sleep GMS were assigned into the generalized tonic-clonic seizures during sleep (S-GTCS) group and the remaining 16 patients were moved into the group with partial epilepsies during sleep (S-PE), comprising a total of 42 patients (Table 1) .
Baseline clinical characteristics
The baseline clinical characteristics found in the two groups of SE are summarized in Table 2 . The mean age of seizure onset, sex ratio, mean duration of illness prior to the initial evaluation and mean baseline seizure frequencies were not significantly different between the two groups. The history of significant remote CNS insults were found in 19 patients: three of 21 patients with S-GTCS and 16 of 42 patients with S-PE, which was not statistically significant (P > 0.05). The history of head trauma associated with a loss of consciousness or amnesia for longer than 30 minutes was found in only one patient with S-GTCS compared with 10 patients with S-PE, which was close to the level of statistical significance (P = 0.06). Family history of epilepsy in the first-degree relatives was found only in two patients each in the S-GTCS and S-PF groups. Histories of febrile convulsions were present in 11 patients (four in S-GTCS and seven in S-PE).
Focal TEDS in the EEG data were found in 23 of 42 patients with S-PE and localized in the temporal lobe in 15 patients (left in six patients, right in eight, bitemporal in one), the left temporo-parieto-occipital region in two patients, the frontal lobe in four patients (left in one patient and right in three patients), the bioccipital lobes in one patient, and the right hemisphere in one patient. Thus temporal lobe involvement was the most common (17 of 23 patients, 73.9%) with comparable lateralization of TEDS between the hemispheres (left, nine patients; right, 12 patients; bilateral, two patients).
The neuroimaging studies showed significant focal lesions in 11 patients with S-PE, which included cavernous angioma (two patients), focal cortical dysplasia (one patient), focal calcified lesions (two patients), cerebromalacia (four patients), hippocampal atrophy (one patient), and cortical tubers with periventricular calcifications (one patient). The lateralization of lesions was also comparable between the hemispheres (left in four patients, right in six, bilateral in one).
Responses to AEDs therapy (i) S-GTCS
Of 21 patients with S-GTCS, 14 patients had had no seizures since their initial visit, one patient was seizurefree for the first year but had seizure recurrences during the second year, and three of six patients with recurrent seizures during the first year achieved a seizurefree outcome at the second year of follow-up, so that seizure-free outcome was achieved in 17 patients. Of four patients with recurrent seizures throughout the 2 years of follow-up, three patients improved and one did not. Therefore, the group of S-GTCS showed an excellent response to AEDs therapy with a terminal l-year seizure remission rate of 8 1% at the end of the 2-year follow-up. Of the many clinical variables analysed (Table 3) , only the longer duration of illness was significantly related to a poor seizure control outcome (P = 0.02). The higher baseline seizure frequency tended to be associated with poor seizure control, but it did not reach a significant level (P = 0.06).
(ii) S-PE Of 42 patients with S-PE, 14 patients were seizurefree following their initial clinic visit and one patient achieved a seizure-free outcome during the second year of follow-up, 23 patients improved and four did not (Table 4) . Of 29 patients who had been exposed to AEDs therapy at their initial clinic visit, 10 patients showed a serum level of AEDs within the therapeutic level, and only one of them achieved a seizure-free outcome. Of 19 patients with subtherapeutic serum levels of AEDs at their initial evaluation, eight patients became seizure-free, 10 patients improved, and one patient did not. Six of 13 patients new to AEDs therapy became seizure-free, six patients improved and one patient did not. Therefore, of 32 patients who had been previously either inadequately treated or untreated, 14 patients became seizure-free (43.8%), 16 patients improved (50%), and two patients did not improve (6.3%). These features were in clear contrast to the outcome of the patients with S-GTCS but were not different from the reported outcomes of previously untreated or undertreated partial epilepsy'3.
For the subgroup analysis of S-PE, we compared the outcomes of 16 patients, who presented with S-GMS but were reclassified into S-PE due to either focal IEDs in EEG or focal lesions found in the neuroimaging studies, with the outcomes of 26 patients who were classified into S-PE due to the unequivocal evidence of partial seizures in phenomenology. Seizure-free outcome was achieved in four of the 16 patients presenting with S-GMS and in 11 of the 26 patients presenting initially with sleep PS, which was not significantly different (P > 0.05). Therefore, the analysis of clinical variables in patients with S-PE did not reveal any significant factors related to the outcome of seizure control.
Development of wake seizure
Throughout the 2-year follow-up period, 34 patients developed recurrent seizures (three patients became seizure-free during the second year) and 12 of them developed WS. There were significant differences in the incidence of WS between the two groups of patients. S-GTCS and S-PE.
(i, S-GTCS
Of 21 patients with S-GTCS, only one of seven patients who had experienced recurrent seizures (three patients became seizure-free in the second year) during the 2 years of follow-up developed new WS. This patient had a history of 13 years of seizure duration with an average baseline seizure frequency of two episodes per month. He was taking phenytoin (PHT) and the serum level was found at the initial evaluation to be 27.75pg/ml. A WS occurred at the 4th month of follow-up. The phenomenology of his WS consisted of-initial vocalization with head turning to the left side followed by GTCS. He also reported an aura consisting of fear just before his loss of consciousness, which was consistent with a partial-onset secondary GTCS.
(io S-PE Table 5 summarized the clinical variables associated with the development of new WS in patients with S-PE. Of 27 patients who had experienced recurrent seizures during the 2 years of follow-up, 11 patients developed WS, and 16 patients continued to have SE. The mean age of onset and sex ratio were not significantly different in the groups of patients with continuing SE and newly developed WS. However, the duration of illness was longer (P = 0.03) and the baseline seizure frequency was higher (P = 0.02) in patients with WS than in patients with recurrent sleep seizures only. The statistical significance of those two variables was further confirmed by the stepwise multiple logistic regression model. The odd ratios for the duration of illness (years) and for the baseline seizure frequency (episodes/year) were 1.3 with 95% confidence intervals of 1.1 to 1.6 and 1.1 to 1.5, respectively. In the subgroup analysis, presence of focal TEDS and the history of remote CNS insults did not show any significant differences from the overall outcomes of S-PE. The incidence of WS was higher in patients with a history of head trauma, but it did not reach a significant level (P = 0.06).
Of 42 patients with S-PE, 40 patients were followed for longer than 2 years (range : 25 to 82 months), and 11 patients (nine of 27 patients with recurrent seizures and two of 13 patients with a seizure-free outcome) newly developed WS during the extended follow-up period. Therefore, 22 of 42 patients with S-PE (52.4%) In this study, we tried to investigate the clinical courses of SE in relation to their seizure types, which has not previously been systematically conducted. The classification of seizure type was made by a thorough history-taking, supplemented by EEG and neuroimaging data, similar to the usual practice. Two-thirds of the patients were successfully classified into S-PE, which was similar to the overall distribution of partial epilepsies in the general population. For patients presenting with generalized convulsions, lacking detailed descriptions about the initial part of attacks and negative results of EEG and neuroimaging studies, the exact diagnosis of seizure types may be problematic. On these occasions a prolonged CCTV-EEG recording may be beneficial, however, its use should be reserved only for selected cases on the basis of careful clinical judgment. Therefore, the inclusion of CCTV-EEG data may not help much for predicting the clinical course of SE at the level of clinic practice.
Sleep GTCS
The clinical courses of 2 1 patients assigned to S-GTCS were characterized by their excellent response to AEDs therapy (seizure-free in 8 1%) comparable to that of idiopathic generalized epilepsies14 and a very rare occurrence of diurnal attacks (4.8%).
It is likely that a large number of these patients may have, in fact, idiopathic GTCS. However, typical generalized SWCs in EEG were seen in only four patients and the descriptions of their seizure onset were often unclear. In addition, the seizure phenomenology of the patient who developed WS was consistent with a partial-onset secondary GTCS. Therefore, it is quite possible that some of these patients might have secondary GTCS instead of idiopathic GTCS. However, all these patients had GTCS only without any known focal features in both clinical and laboratory investigations, which was clearly different from the group of S-PE. Even in patients with PE, as recently reported by Mattson et al 15, the prognosis for secondary GTCS alone was far better than for CPS alone or mixed seizures. Thus, from a clinical aspect, it seems reasonable to treat them all as one group, S-GTCS.
Idiopathic GTCS alone is a clinical entity found in approximately 25% of all idiopathic generalized epilepsies and usually characterized by its benign course with infrequent attacks16. At present, GTCS on awakening is the only epileptic syndrome applicable to this group of patients but this syndrome has recently been disputed because a large proportion of patients with GTCS alone do not fit its criteria. Reutens and Berkovic" investigated 101 patients with idiopathic generalized epilepsies and found 17 patients with GTCS alone. Of those, 10 patients did fit the criteria of GTCS on awakening. Three of the remaining seven patients had true sleep GTCS which was characterized by a very low frequency of seizures, usually less than one episode per month or less than 10 seizures in total, and an excellent response to AEDs therapy. Sleep GTCS was also found in five of 84 patients with eitberjuvenile myoclonic epilepsy or absence epilepsy, which were excluded from this study. The relationship between the occurrence of seizures and circadian rhythm seems to be a rule for idiopathic generalized epilepsies17 and their mechanisms share common neuroanatomical structures (brainstem and thalamus), thus it is quite likely that a proportion of idiopathic GTCS alone may have an intimate relationship with sleep and behave like pure SE. The mean duration of pure S-GTCS in our four patients with generalized SWC was 8 years (range : 3 to 13 years) with infrequent seizures (range : 0.3 to 3 episodes/year) and all of them entered into a prolonged remission after appropriate AEDs therapy. These patients were quite similar to the three patients described by Reutens and Berkovic" and they might be considered as idiopathic S-GTCS with reference to the GTCS on awakening characteristic.
Despite the uncertainties about the true types of epilepsy in patients with S-GTCS, we were able to conclude that the patients presenting with recurrent sleep GMS without any focal features in seizure phenomenology, EEG and neuroimaging studies carry an excellent prognosis and the chance of developing new WS is very low.
Sleep partial epilepsy
The clinical courses of the patients with S-PE were quite different from the group of S-GTC, as was characterized by their poor responses to AEDs therapy and much higher incidence of WS. Seizure-free outcome was achieved in 15 of42 patients (35.7%) or in six of 13 patients (46.2%) new to AEDs, which was essentially similar to the general seizure control outcome in partial epilepsy .
I3 However, the incidence of focal lesions in MRI (eight of 27 patients: 29.6%) was relatively lower in this group of patients than in the general population of partial epilepsy patients attending the epilepsy clinic. The incidence of focal lesions in MRI in patients with partial epilepsy was 51.4% in the study of Resta et a/l7 and was 5 1.6% in our epilepsy clinic" with hippocampal sclerosis being the most frequent (59.4% of all lesions). In this study the typical MRI features of hippocampal sclerosis was found in only one patient despite 15 patients showing localized focal IEDs in the temporal lobe in EEG. The reason for the lower incidence of hippocampal sclerosis in our patients with S-PE is unclear, however, the lower incidence of focal lesions and the diverse nature and location of pathologies found in this group of patients suggest that focal lesions are not specifically related to SE, which is in agreement with the data of Young ei al'. The high incidence of the history of significant head trauma in this population (23.8%) was an interesting phenomenon as previously suggested by Young et al'. We speculate that shearing injury to the brainstem, a structure responsible for the modulation of sleep-wake cycles, by a significant closed head injury may be related in some way with the subsequent development of SE. The relationship between post-traumatic epilepsy and sleep clearly needs further investigation.
The high incidence of WS in this group of patients, especially in patients with prolonged duration of pure S-PE, was an unexpected finding. Of 27 patients with recurrent sleep attacks, 11 developed new WS during the 2 years of follow-up and we were able to find 11 additional patients who developed new WS during their extended follow-up of 47.8 f 15.9 months, which suggested that the development of WS was quite high in patients with S-PE unless their seizures were completely controlled throughout.
Previous investigators suggested that the risk of WS was higher in patients with a shorter duration of illness'*4,5. In contrast, the incidence of WS was higher in patients with longer duration and higher baseline seizure frequencies in this study. The average duration of illness from the onset of SE to the development of WS in these patients was 131.1 f 87.2 months and the baseline seizure frequency was 17.9 f 16.6 episodes per year. Although no specific duration of illness associated with the development of WS could be found in this study, our data indicated that a longer duration of illness increases the risk of developing WS by the rate of 1.3 per year (95% CI: 1.1 to 1.6), which argues against the previous concepts on the importance of an initial several years of follow-up to be able to diagnose pure SE.
Reasons for these differences from previous studies are unclear but may be related to two possibilities. First, previous investigators had included both partial and generalized SE, which might have diluted the higher incidence of diurnal attacks in patients with S-PE. Second, a majority of the patients recruited to the previous studies had a shorter duration of SE, but a larger proportion of S-PE in this study (25 of 42 patients) had longer than 3 years of seizure duration at the time of initial evaluation, which was probably related to the different social environment. There is a strong social stigma against epilepsy in Korean society, probably related to a long traditional Confucian concept stressing a strict moral code in social activities, which might interfere with patients seeking medical care or exposing their illness, especially when their seizures occur exclusively during sleep.
Recently, Shinnar er al*' investigated the risk of subsequent recurrent seizures in patients registered after their tirst unprovoked seizure. Interestingly, the chance of recurrent seizures was higher in patients who had their first seizure during sleep, and their subsequent seizures were more likely to occur during sleep. If the patient had the first two seizures during sleep, the probability of having their third seizure during sleep was approximately 90%. These findings clearly suggest that there is a group of patients having closer interactions between sleep and epilepsy, but with variable degrees of interaction in different individuals.
The group of patients with shorter duration of pure SE may include many patients with looser interactions between sleep and seizure occurrence, who will develop WS early. In contrast, the group of patients with a longer duration of pure SE may represent the presence of stronger interactions. However, unless the degree of interactions was total, the chance of developing WS may increase as they continue to have more seizure recurrences over a prolonged period, thus the chance of developing WS may be higher in patients with a longer duration of pure S-PE. This hypothesis that, the more seizures the patient has, the higher the risk of developing WS, is also in agreement with the strong effect of higher seizure frequencies on the risk of developing new WS. This is again consistent with the fact that infrequent seizure recurrence was one of the characteristics of pure SE both in humans'*5 and kindled animals*l . It seems apparent that the less frequent seizure recurrences should prolong the duration of pure SE, however, they may develop new WS eventually as they continue to have recurrent seizures over a longer period,
We conclude that a thorough evaluation of the patients with S-PE is crucial for predicting their future clinical course. Patients with S-GTCS without any focal features in seizure phenomenology, EEG and neuroimaging studies easily enter into a prolonged seizure remission and the risk of developing WS is quite low. With respect to the GTCS on awakening criterion, some S. A. Park et 8/ of these patients (especially those having infrequent attacks) may have idiopathic S-GTCS. On the other hand, patients with S-PE were associated with unfavorable seizure control outcomes and a high incidence of developing WS. In this group of patients the risk of developing WS may increase if patients continue to have recurrent seizures over a longer period, which suggests that the interactions between sleep and seizure occurrences are not absolute.
